Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2015

Open Access 01-12-2015 | Research Article

Comparison of different approaches to estimating age standardized net survival

Authors: Paul C. Lambert, Paul W. Dickman, Mark J. Rutherford

Published in: BMC Medical Research Methodology | Issue 1/2015

Login to get access

Abstract

Background

Age-standardized net survival provides an important population-based summary of cancer survival that appropriately accounts for differences in other-cause mortality rates and standardizes the population age distribution to allow fair comparisons. Recently, there has been debate over the most appropriate method for estimating this quantity, with the traditional Ederer II approach being shown to have potential bias.

Methods

We compare lifetable-based estimates (Ederer II), a new unbiased method based on inverse probability of censoring weights (Pohar Perme) and model-based estimates. We make the comparison in a simulation setting; generating scenarios where we would expect to see a large theoretical bias.

Results

Our simulations demonstrate that even in relatively extreme scenarios there is negligible bias in age-standardized net survival when using the age-standardized Ederer II method, modelling with continuous age or using the Pohar Perme method. However, both the Ederer II and modelling approaches have some advantages over the Pohar Perme method in terms of greater precision, particularly for longer-term follow-up (10 and 15 years).

Conclusions

Our results show that, when age-standardizing, concern over bias with the traditional methods is unfounded. We have also shown advantages in using the more traditional and modelling methods.
Appendix
Available only for authorised users
Literature
3.
go back to reference Derolf ÅR, Kristinsson SY, Andersson TM-L, Landgren O, Dickman PW, Bjørkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood. 2009; 113(16):3666–72. doi:10.1182/blood-2008-09-179341.CrossRefPubMed Derolf ÅR, Kristinsson SY, Andersson TM-L, Landgren O, Dickman PW, Bjørkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood. 2009; 113(16):3666–72. doi:10.​1182/​blood-2008-09-179341.CrossRefPubMed
5.
go back to reference Coleman MP, Quaresma M, Berrino F, Lutz JM, Angelis RD, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008; 9(8):730–56.CrossRefPubMed Coleman MP, Quaresma M, Berrino F, Lutz JM, Angelis RD, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008; 9(8):730–56.CrossRefPubMed
6.
go back to reference Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet. 2011; 377:127–38.CrossRefPubMedPubMedCentral Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet. 2011; 377:127–38.CrossRefPubMedPubMedCentral
7.
go back to reference Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000; 19(13):1729–1740.CrossRefPubMed Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000; 19(13):1729–1740.CrossRefPubMed
9.
go back to reference Møller H, Sandin F, Bray F, Klint A, Linklater KM, Purushotham A, et al. Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer. 2010; 127:2630–8.CrossRefPubMed Møller H, Sandin F, Bray F, Klint A, Linklater KM, Purushotham A, et al. Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer. 2010; 127:2630–8.CrossRefPubMed
11.
go back to reference Morris EJA, Sandin F, Lambert PC, Bray F, Klint Å, Linklater K, et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut. 2011; 60(8):1087–1093. doi:10.1136/gut.2010.229575.CrossRefPubMed Morris EJA, Sandin F, Lambert PC, Bray F, Klint Å, Linklater K, et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut. 2011; 60(8):1087–1093. doi:10.​1136/​gut.​2010.​229575.CrossRefPubMed
12.
13.
go back to reference Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax. 2010; 65(5):436–41. doi:10.1136/thx.2009.124222.CrossRefPubMed Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax. 2010; 65(5):436–41. doi:10.​1136/​thx.​2009.​124222.CrossRefPubMed
17.
go back to reference Lambert PC, Dickman PW, Nelson CP, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med. 2010; 29:885–95.CrossRefPubMed Lambert PC, Dickman PW, Nelson CP, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med. 2010; 29:885–95.CrossRefPubMed
18.
go back to reference Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. methodological note no. 10, end results evaluation section. Bethesda, MD: Technical report, National Cancer Institute; 1959. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. methodological note no. 10, end results evaluation section. Bethesda, MD: Technical report, National Cancer Institute; 1959.
23.
24.
go back to reference Rutherford MJ, Crowther MJ, Lambert PC. The use of restricted cubic splines to approximate complex hazard functions in the analysis of time-to-event data: a simulation study. J Stat Comput Simul. 2015; 85:777–93.CrossRef Rutherford MJ, Crowther MJ, Lambert PC. The use of restricted cubic splines to approximate complex hazard functions in the analysis of time-to-event data: a simulation study. J Stat Comput Simul. 2015; 85:777–93.CrossRef
27.
go back to reference Roche L, Danieli C, Belot A, Grosclaude P, Bouvier AM, Velten M, et al. Cancer net survival on registry data: Use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer. 2012; 132(10):2359–69. doi:10.1002/ijc.27830.CrossRefPubMed Roche L, Danieli C, Belot A, Grosclaude P, Bouvier AM, Velten M, et al. Cancer net survival on registry data: Use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer. 2012; 132(10):2359–69. doi:10.​1002/​ijc.​27830.CrossRefPubMed
28.
go back to reference Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982; 38(4):933–42.CrossRefPubMed Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982; 38(4):933–42.CrossRefPubMed
Metadata
Title
Comparison of different approaches to estimating age standardized net survival
Authors
Paul C. Lambert
Paul W. Dickman
Mark J. Rutherford
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2015
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-015-0057-3

Other articles of this Issue 1/2015

BMC Medical Research Methodology 1/2015 Go to the issue